1 / 5

Strengthening the FDA: Insights from CDER Funding FY 2008-2016

This document from the Alliance for a Stronger FDA discusses the funding allocated to the Center for Drug Evaluation and Research (CDER) for fiscal years 2008 through 2016. It highlights the impact of sequestration on funding in FY 2013, with subsequent projections for FY 2015 based on the President's Budget and FY 2016 based on HHS estimations. The analysis aims to provide insight into the funding challenges and strategies for enhancing CDER's capacity to ensure public health and safety through effective drug evaluation.

buzz
Télécharger la présentation

Strengthening the FDA: Insights from CDER Funding FY 2008-2016

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Alliance for a Stronger FDA July 10, 2014 Center for Drug Evaluation and Research (CDER) CONFIDENTIAL

  2. CDER Sentinel Funding FY 2008- FY 2013

  3. FY 2013 includes a reduction in BA due to sequestration. FY 2015 is based on the FY 2015 President’s Budget and FY 2016 is based on the FY 2016 HHSJ.

  4. FY 2013 includes a reduction in BA due to sequestration. FY 2015 is based on the FY 2015 President’s Budget and FY 2016 is based on the FY 2016 HHSJ.

More Related